developed a fully automated system incorporating T-maze alternation, novel object recognition, and object-in-place recognition tests combined with continuous locomotion and quiescence monitoring, capable of discriminating between hippocampal lesion types and predicting Alzheimer's disease model genotypes (Ho et al., 2023, DOI)
Jan 16 2022;11(1)doi:10.3390/antiox11010167 Khaw SC, Wong ZZ, Anderson R, Martins da Silva S
Bodenheimer has received speaker honoraria and research support from Roche Pharmaceuticals and Schering Plough and has served on the advisory board of Roche Pharmaceuticals
NHS availability would require both MHRA approval and a positive NICE technology appraisal
When you eat very little, every bite you do take becomes incredibly important